| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/01/2011 | CN102078453A Traditional Chinese medicine for treating oculopathy |
| 06/01/2011 | CN102078446A Chinese medicine powder for treating deafness |
| 06/01/2011 | CN102078430A Chinese traditional medicine for treating tympanitis |
| 06/01/2011 | CN102078397A Traditional Chinese medicine compound and preparation method thereof |
| 06/01/2011 | CN102078343A Application of ginkgo leaf total lactones in preparation of medicament for preventing or treating deafness and tinnitus |
| 06/01/2011 | CN102078297A Method for preparing osmotic diuretic injection containing high oxygen or electrolyte |
| 06/01/2011 | CN102078287A Ophthalmic gel of artificial musk and preparation method thereof |
| 06/01/2011 | CN101670057B Compound ear dropping liquid for treating suppurative otitis media |
| 06/01/2011 | CN101601659B Glutathione enteric-coated pellet and preparation method thereof |
| 05/31/2011 | US7951845 Composition and method of treating hearing loss |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | CA2492739C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/31/2011 | CA2491312C Bioerodible film for ophthalmic drug delivery |
| 05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/26/2011 | WO2011063394A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 05/26/2011 | WO2011063276A1 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 05/26/2011 | WO2011063178A2 Intravenous infusion of curcumin and a calcium channel blocker |
| 05/26/2011 | WO2011063161A2 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr) |
| 05/26/2011 | WO2011063005A2 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| 05/26/2011 | WO2011061298A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
| 05/26/2011 | WO2011003103A3 Pharmacology of visual cycle modulators |
| 05/26/2011 | WO2010136311A3 Compositions and methods for antibodies targeting complement protein c3b |
| 05/26/2011 | US20110124737 Enhanced bimatoprost ophthalmic solution |
| 05/26/2011 | US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors |
| 05/26/2011 | US20110124725 Treatment for Meibomian Gland Dysfunction or Obstruction |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124708 Rnai-mediated inhibition of ocular hypertension targets |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 05/26/2011 | US20110124682 Pharmaceutical composition comprising rebamipide |
| 05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124646 Novel cyclic compound having pyrimidinylalkylthio group |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124616 Method for treating retinal conditions using an intraocular tamponade |
| 05/26/2011 | US20110124596 Composition for treating inflammatory diseases |
| 05/26/2011 | US20110123647 Use of extracts of capraria biflora in the prevention and/or treatment of senile cataracts |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123622 Ophthalmic formulation and method of manufacture thereof |
| 05/26/2011 | US20110123528 Humanized anti-factor d antibodies and uses thereof |
| 05/26/2011 | US20110123525 Anti-angiogenic therapy |
| 05/26/2011 | CA2781698A1 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 05/26/2011 | CA2781290A1 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr) |
| 05/26/2011 | CA2781149A1 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| 05/26/2011 | CA2781139A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
| 05/26/2011 | CA2780756A1 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324823A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 05/25/2011 | EP2324032A2 Inhibitors of beta-secretase |
| 05/25/2011 | EP2323736A1 Treatment of fibrotic eye disorders using an mmp2 inhibitor |
| 05/25/2011 | EP2323661A1 A3 adenosine receptor allosteric modulators |
| 05/25/2011 | EP2323657A1 Ophthalmic pharmaceutical compositions comprising sorafenib for the treatment of neoangiogenic pathologies of the eye |
| 05/25/2011 | EP2323642A1 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |
| 05/25/2011 | EP2323637A1 Treatment of fibrotic eye disorders |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 05/25/2011 | CN1976692B Methods and compositions for treating ophthalmic conditions with retinyl derivates |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076681A Substituted gamma lactams as therapeutic agents |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 05/25/2011 | CN102076339A Use of epothelone d in treating tau-associated diseases including alzheimer's disease |
| 05/25/2011 | CN102076336A Compounds useful for the prevention or treatment of accomodative asthenopia |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070712A VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
| 05/25/2011 | CN102070618A Compound and crystals thereof |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102068689A Swine alum powder |
| 05/25/2011 | CN102068577A Traditional Chinese medicine (TCM) composition and application thereof |
| 05/25/2011 | CN102068543A Chinese medicinal composition for treating suppurative otitis media |
| 05/25/2011 | CN102068485A Preparation and application of high-efficiency and low-toxicity effective fraction for suppressing angiogenesis in silktree albizzia bark |
| 05/25/2011 | CN102068481A Preparation and application of low-toxicity effective fraction for suppressing angiogenesis in cowherb seed |
| 05/25/2011 | CN102068472A Preparation method for traditional Chinese medicinal pubescent holly root injection |
| 05/25/2011 | CN102068458A Eyesight improving product |
| 05/25/2011 | CN102068426A New application of Ginkgolide B derivative in medicament preparation |
| 05/25/2011 | CN101843781B Chinese medicinal composition for preventing and treating xerophthalmia |
| 05/25/2011 | CN101653499B New application of peony blood stasis removing preparation in preparing medicaments for preventing or treating diabetic complication |
| 05/25/2011 | CN101439131B Chinese medicinal composition for treating phonosensitive nerve deafness and use thereof |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101015628B Chinese medicine for improving eyesight |
| 05/24/2011 | US7947740 Bimatoprost crystalline form I |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2428985C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2341507C Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |